<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">sechenov</journal-id><journal-title-group><journal-title xml:lang="en">Sechenov Medical Journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Сеченовский вестник</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2218-7332</issn><issn pub-type="epub">2658-3348</issn><publisher><publisher-name>Сеченовский Университет</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">sechenov-551</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>URGENT PROBLEMS OF SURGERY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ХИРУРГИИ</subject></subj-group></article-categories><title-group><article-title>SOLUBLE DIFFERENTIATING ANTIGENS AND HISTOCOMPATIBILITY MOLECULES IN PATIENTS WITH DIFFERENT KIND OF TRAUMA</article-title><trans-title-group xml:lang="ru"><trans-title>РАСТВОРИМЫЕ ДИФФЕРЕНЦИРОВОЧНЫЕ АНТИГЕНЫ И МОЛЕКУЛЫ ГИСТОСОВМЕСТИМОСТИ У ПАЦИЕНТОВ С РАЗЛИЧНЫМИ ВИДАМИ ТРАВМ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Караулов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Karaulov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Заведующий кафедрой клинической имунологии и аллергологии, д.м.н., профессор, член-корреспондент РАМН</p></bio><email xlink:type="simple">karaulov@mtu-net.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лебедев</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Lebedev</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Руководитель отделения лабораторной диагностики, к.м.н.</p></bio><email xlink:type="simple">miklgito@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новиков</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Директор НИИ молекулярной биологии и региональной экологии, д.б.н., профессор</p></bio><email xlink:type="simple">mbre@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Первый московский государственный медицинский университет им. И.М. Сеченова</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>ФГУ «Нижегородский научно-исследовательский институт травматологии и ортопедии федерального агентства по высокотехнологичной медицинский помощи» (ФГУ «ННИИТО Росмедтехнологий»)</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>ГОУ ВПО «Нижегородский государственный университет им. Н.И.Лобачевского» Федерального агенства образования РФ (ННГУ им. Н.И.Лобачевского)</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>30</day><month>03</month><year>2010</year></pub-date><volume>0</volume><issue>1</issue><fpage>63</fpage><lpage>68</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Karaulov A.V., Lebedev M.Y., Novikov V.V., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Караулов А.В., Лебедев М.Ю., Новиков В.В.</copyright-holder><copyright-holder xml:lang="en">Karaulov A.V., Lebedev M.Y., Novikov V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sechenovmedj.com/jour/article/view/551">https://www.sechenovmedj.com/jour/article/view/551</self-uri><abstract><p>In biological fluids of trauma patients the essential changes in soluble forms of immune system cells membrane antigens in different states have been revealed. The soluble forms of membrane antigens, which can makes up oligomers, consists of subunits, belong to one antigen, or which can make up soluble complexes (associations), composed of pair receptor–ligand. The changes in concentration of soluble analogs of membrane antigens in patients with mechanical injury, craniocerebral trauma and burning injury are the perspective prognostic markers of possibility of development complication. The state of soluble differentiation molecules pool is one from factors which define the outcomes of underlying disease. Peculiarity of immune system cells transcriptome, associated with mRNA of soluble and membrane differentiation antigens have prognostic character in trauma patients.</p></abstract><trans-abstract xml:lang="ru"><p>При травматологической патологии различного генеза в биологических жидкостях пациентов выявлены существенные изменения в содержании растворимых форм мембранных антигенов клеток иммунной системы, находящихся в разном структурно-функциональном состоянии. У больных обнаружены растворимые формы мембранных антигенов, которые могут образовывать олигомеры, состоящие из субъединиц, принадлежащих одному антигену, или растворимые комплексы (ассоциаты), построенные из пар рецептор–лиганд. Изменения в концентрации растворимых аналогов мембранных антигенов у пострадавших в результате механической, черепно-мозговой и ожоговой травмы являются перспективными прогностическими маркерами возможности развития осложнений. Состояние пула растворимых дифференцировочных молекул клеток иммунной системы – один из факторов, обусловливающих исход основного заболевания. Особенности транскриптома клеток иммунной системы, связанные с матричной РНК растворимых и мембранных дифференцировочных антигенов у пациентов травматологического профиля, имеют прогностический характер.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>механическая травма</kwd><kwd>черепно-мозговая травма</kwd><kwd>ожоги</kwd><kwd>растворимые дифференцировочные антигены</kwd><kwd>молекулы гистосовместимости</kwd><kwd>регуляция иммунного ответа</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mechanical injury</kwd><kwd>craniocerebral trauma</kwd><kwd>burning injury</kwd><kwd>soluble differentiation antigens</kwd><kwd>molecules of histocompatibility</kwd><kwd>immune response regulation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков В.В., Караулов А.В., Барышников А.Ю. Растворимые формы мембранных антигенов клеток иммунной системы. М:МИА, 2008.</mixed-citation><mixed-citation xml:lang="en">Новиков В.В., Караулов А.В., Барышников А.Ю. Растворимые формы мембранных антигенов клеток иммунной системы. М:МИА, 2008.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Prasad K.S., Andre P., He M. et al. Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc. Natl. Acad. Sci. USA, 2003;100:12367–12371.</mixed-citation><mixed-citation xml:lang="en">Prasad K.S., Andre P., He M. et al. Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc. Natl. Acad. Sci. USA, 2003;100:12367–12371.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков В.В. Растворимые формы дифференцировочных антигенов гемопоэтических клеток. Гематология и трансфузиология. 1996;6:40–43.</mixed-citation><mixed-citation xml:lang="en">Новиков В.В. Растворимые формы дифференцировочных антигенов гемопоэтических клеток. Гематология и трансфузиология. 1996;6:40–43.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Troelstra A., Giepmans B.N., Van Kessel K.P. et al. Dual effects of soluble CD14 on LPS priming of neutrophils. J. Leukoc. Biol. 1997;61(2):173–178.</mixed-citation><mixed-citation xml:lang="en">Troelstra A., Giepmans B.N., Van Kessel K.P. et al. Dual effects of soluble CD14 on LPS priming of neutrophils. J. Leukoc. Biol. 1997;61(2):173–178.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Heaney M. L., Golde D.W. Soluble cytokine receptors. Blood. 1996;87(3):847–857.</mixed-citation><mixed-citation xml:lang="en">Heaney M. L., Golde D.W. Soluble cytokine receptors. Blood. 1996;87(3):847–857.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Walsh D.S., Siritongtaworn P., Pattanapanyasat K. et al. Lymphocyte activation after non-thermal trauma. Br. J. Surg. 2000;87:223–230.</mixed-citation><mixed-citation xml:lang="en">Walsh D.S., Siritongtaworn P., Pattanapanyasat K. et al. Lymphocyte activation after non-thermal trauma. Br. J. Surg. 2000;87:223–230.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Schinkel C., Faist E., Zimmer S. et al. Kinetics of circulating adhesion molecules and chemokines after mechanical trauma and burns. Eur. J. Surg. 1996;162:763–768.</mixed-citation><mixed-citation xml:lang="en">Schinkel C., Faist E., Zimmer S. et al. Kinetics of circulating adhesion molecules and chemokines after mechanical trauma and burns. Eur. J. Surg. 1996;162:763–768.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Boldt J., Muller M., Kuhn D. et al. Circulating adhesion molecules in the critically ill:a comparison between trauma and sepsis patients. Intensive Care Med. 1996;22:122–128.</mixed-citation><mixed-citation xml:lang="en">Boldt J., Muller M., Kuhn D. et al. Circulating adhesion molecules in the critically ill:a comparison between trauma and sepsis patients. Intensive Care Med. 1996;22:122–128.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Maier B., Lefering R., Lehnert M. et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock. 2007;28:668–674.</mixed-citation><mixed-citation xml:lang="en">Maier B., Lefering R., Lehnert M. et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock. 2007;28:668–674.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Briassoulis G., Papassotiriou I., Mavrikiou M. et al. Longitudinal course and clinical significance of TGF-beta1, sL- and sESelectins and sICAM-1 levels during severe acute stress in children. Clin Biochem. 2007;40:299–304.</mixed-citation><mixed-citation xml:lang="en">Briassoulis G., Papassotiriou I., Mavrikiou M. et al. Longitudinal course and clinical significance of TGF-beta1, sL- and sESelectins and sICAM-1 levels during severe acute stress in children. Clin Biochem. 2007;40:299–304.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Uzan M., Erman H., Tanriverdi T. et al. Evaluation of apoptosis in cerebrospinal fluid of patients with severe head injury. Acta Neurochir. 2006;148:1157–1164.</mixed-citation><mixed-citation xml:lang="en">Uzan M., Erman H., Tanriverdi T. et al. Evaluation of apoptosis in cerebrospinal fluid of patients with severe head injury. Acta Neurochir. 2006;148:1157–1164.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Шолкина М.Н. Состояние клеточного иммунитета у пациентов с тяжелой черепно-мозговой травмой: Автореф. дисс. … канд. мед. наук. М., 2005. 22 с.</mixed-citation><mixed-citation xml:lang="en">Шолкина М.Н. Состояние клеточного иммунитета у пациентов с тяжелой черепно-мозговой травмой: Автореф. дисс. … канд. мед. наук. М., 2005. 22 с.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Teodorczyk-Injeyan J.A., McRitchie D.I., Peters W.J., et al. Expression and secretion of IL-2 receptor in trauma patients. Ann. Surg. 1990;212:202–208.</mixed-citation><mixed-citation xml:lang="en">Teodorczyk-Injeyan J.A., McRitchie D.I., Peters W.J., et al. Expression and secretion of IL-2 receptor in trauma patients. Ann. Surg. 1990;212:202–208.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Teodorczyk-Injeyan J.A., Sparkes B.G., Lalani S. et al. IL-2 regulation of soluble IL-2 receptor levels following thermal injury. Clin. Exp. Immunol. 1992;90(1):36–42.</mixed-citation><mixed-citation xml:lang="en">Teodorczyk-Injeyan J.A., Sparkes B.G., Lalani S. et al. IL-2 regulation of soluble IL-2 receptor levels following thermal injury. Clin. Exp. Immunol. 1992;90(1):36–42.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Teodorczyk-Injeyan J.A., Sparkes B.G., Mills G.B., Peters W.J. Immunosuppression follows systemic T lymphocyte activation in the burn patient. Clin Exp Immunol. 1991;85(3):515–518.</mixed-citation><mixed-citation xml:lang="en">Teodorczyk-Injeyan J.A., Sparkes B.G., Mills G.B., Peters W.J. Immunosuppression follows systemic T lymphocyte activation in the burn patient. Clin Exp Immunol. 1991;85(3):515–518.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Peteiro-Cartelle F.J., Alvarez-Jorge A. Dynamic profiles of interleukin-6 and the soluble form of CD25 in burned patients. Burns. 1999;25:487–491.</mixed-citation><mixed-citation xml:lang="en">Peteiro-Cartelle F.J., Alvarez-Jorge A. Dynamic profiles of interleukin-6 and the soluble form of CD25 in burned patients. Burns. 1999;25:487–491.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Schleter B., Konig W, Koller M. et al. Studies on B-lymphocyte dysfunctions in severely burned patients. J. Trauma. 1990;30(11):1380–1389.</mixed-citation><mixed-citation xml:lang="en">Schleter B., Konig W, Koller M. et al. Studies on B-lymphocyte dysfunctions in severely burned patients. J. Trauma. 1990;30(11):1380–1389.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Schleter B., Konig W., Koller M. еt al. Differential regulation of T- and B-lymphocyte activation in severely burned patients. J. Trauma. 1991;31( 2):239–246.</mixed-citation><mixed-citation xml:lang="en">Schleter B., Konig W., Koller M. еt al. Differential regulation of T- and B-lymphocyte activation in severely burned patients. J. Trauma. 1991;31( 2):239–246.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kruger C., Schott C., Obertacke U. et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 1991;85(2) :297–301.</mixed-citation><mixed-citation xml:lang="en">Kruger C., Schott C., Obertacke U. et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 1991;85(2) :297–301.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Rokita E., Menzel E.J. Characteristics of CD14 shedding from human monocytes. Evidence for the competition of soluble CD14 (sCD14) with CD14 receptors for lipopolysaccharide (LPS) binding. APMIS. 1997;105(7):510–588.</mixed-citation><mixed-citation xml:lang="en">Rokita E., Menzel E.J. Characteristics of CD14 shedding from human monocytes. Evidence for the competition of soluble CD14 (sCD14) with CD14 receptors for lipopolysaccharide (LPS) binding. APMIS. 1997;105(7):510–588.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yao Y., Yu Y., Wu Y. et al. The significance of changes in serum soluble lipopolysaccharide receptor CD14 levels in burned patients with multiple organ dysfunction syndrome. 1998;36:668–670.</mixed-citation><mixed-citation xml:lang="en">Yao Y., Yu Y., Wu Y. et al. The significance of changes in serum soluble lipopolysaccharide receptor CD14 levels in burned patients with multiple organ dysfunction syndrome. 1998;36:668–670.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sheehab Eldin S.A., Aref S.S., Salama O.S. Assessment of certain neutrophil receptors, opsonophagocytosis and soluble intercellular adgesion molecule (ICAM-1) following thermal injury. Burns 1999;25(5):395–401.</mixed-citation><mixed-citation xml:lang="en">Sheehab Eldin S.A., Aref S.S., Salama O.S. Assessment of certain neutrophil receptors, opsonophagocytosis and soluble intercellular adgesion molecule (ICAM-1) following thermal injury. Burns 1999;25(5):395–401.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kuang X, Ma K, Duan T. The significance of postburn changes in plasma levels of ICAM-1, IL-10 and TNFalpha during early postburn stage in burn patients. Zhonghua Shao Shang Za Zhi. 2002;18(5):302–304.</mixed-citation><mixed-citation xml:lang="en">Kuang X, Ma K, Duan T. The significance of postburn changes in plasma levels of ICAM-1, IL-10 and TNFalpha during early postburn stage in burn patients. Zhonghua Shao Shang Za Zhi. 2002;18(5):302–304.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Law MM, Cryer HG, Abraham E. Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patients. J Trauma. 1994;37(1):100–109.</mixed-citation><mixed-citation xml:lang="en">Law MM, Cryer HG, Abraham E. Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patients. J Trauma. 1994;37(1):100–109.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Бабаев А.А., Кравченко Г.А., Ятманова Т.А. и др. Растворимые комплексы молекул адгезии в сыворотке крови человека. Вестник ННГУ. Cерия «Биология». 2006;1(11):128–132.</mixed-citation><mixed-citation xml:lang="en">Бабаев А.А., Кравченко Г.А., Ятманова Т.А. и др. Растворимые комплексы молекул адгезии в сыворотке крови человека. Вестник ННГУ. Cерия «Биология». 2006;1(11):128–132.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lebedev M. Ju., Egorova N.I., Sholkina M.N., et al. Serum levels of different forms of soluble CD38 antigens in burned patients. Burns. 2004;30(6):552–556.</mixed-citation><mixed-citation xml:lang="en">Lebedev M. Ju., Egorova N.I., Sholkina M.N., et al. Serum levels of different forms of soluble CD38 antigens in burned patients. Burns. 2004;30(6):552–556.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Lebedev M. Ju., Novikova N. A., Novikov V. V. Apoptosis of peripheral blood mononuclear cells in patients after a thermal trauma. Int. J on Immunorehabilitation. 1999;14:105–105.</mixed-citation><mixed-citation xml:lang="en">Lebedev M. Ju., Novikova N. A., Novikov V. V. Apoptosis of peripheral blood mononuclear cells in patients after a thermal trauma. Int. J on Immunorehabilitation. 1999;14:105–105.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Lebedev M. Ju., Ptitsina Ju. S., Vilkov S.A. et al. Membrane and soluble forms of Fas (CD95) in peripheral blood lymphocytes and in serum from burns patients. Burns. 2001;27(7):669–673.</mixed-citation><mixed-citation xml:lang="en">Lebedev M. Ju., Ptitsina Ju. S., Vilkov S.A. et al. Membrane and soluble forms of Fas (CD95) in peripheral blood lymphocytes and in serum from burns patients. Burns. 2001;27(7):669–673.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Teodorczyk-Injeyan J.A., Sparkes B.G., Mills G.B., Peters W.J. Soluble interleukin 2-receptor alpha secretion is related to altered interleukin 2 production in thermally injured patients. Burns. 1991;17(4):290–295.</mixed-citation><mixed-citation xml:lang="en">Teodorczyk-Injeyan J.A., Sparkes B.G., Mills G.B., Peters W.J. Soluble interleukin 2-receptor alpha secretion is related to altered interleukin 2 production in thermally injured patients. Burns. 1991;17(4):290–295.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Уткин О.В., Новиков В.В. Лебедев М.Ю. Содержание суммарной и олигомерной фракций растворимого CD95 антигена в сыворотке крови при ожогах. Вестник ННГУ. Cерия «Биология». 2006;1(11):146–149.</mixed-citation><mixed-citation xml:lang="en">Уткин О.В., Новиков В.В. Лебедев М.Ю. Содержание суммарной и олигомерной фракций растворимого CD95 антигена в сыворотке крови при ожогах. Вестник ННГУ. Cерия «Биология». 2006;1(11):146–149.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Уткин О.В., Лебедев М.Ю., Новиков Д.В. и др. Спектр матричных РНК Fas антигена мононуклеарных клеток крови и сывороточное содержание растворимого Fas у тяжело обожженных больных. Иммунология. 2008;6:372–375.</mixed-citation><mixed-citation xml:lang="en">Уткин О.В., Лебедев М.Ю., Новиков Д.В. и др. Спектр матричных РНК Fas антигена мононуклеарных клеток крови и сывороточное содержание растворимого Fas у тяжело обожженных больных. Иммунология. 2008;6:372–375.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков Д.В., Лебедев М.Ю., Уткин О.В. и др. Метод сравнительной оценки экспрессии мРНК мембранной и доминирующей растворимой форм Fas-антигена с использовани- ем ПЦР в реальном времени. Материалы. III Московского Международного конгресса «Биотехнология: состояние и перспективы развития». 2005. Ч. 1:195–195.</mixed-citation><mixed-citation xml:lang="en">Новиков Д.В., Лебедев М.Ю., Уткин О.В. и др. Метод сравнительной оценки экспрессии мРНК мембранной и доминирующей растворимой форм Fas-антигена с использовани- ем ПЦР в реальном времени. Материалы. III Московского Международного конгресса «Биотехнология: состояние и перспективы развития». 2005. Ч. 1:195–195.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков В.В., Бабаев А.А., Кравченко Г.А. и др. Растворимые ассоциаты молекул адгезии CD54 и CD18 в сыворотке крови человека. Иммунология. 2008;4:220–223.</mixed-citation><mixed-citation xml:lang="en">Новиков В.В., Бабаев А.А., Кравченко Г.А. и др. Растворимые ассоциаты молекул адгезии CD54 и CD18 в сыворотке крови человека. Иммунология. 2008;4:220–223.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Бабаев А.А. Сывороточный уровень адгезивной молекулы CD18 в крови пациентов с ожоговой травмой. Актуальные проблемы медицины и биологии. 2004;3(2):294–295.</mixed-citation><mixed-citation xml:lang="en">Бабаев А.А. Сывороточный уровень адгезивной молекулы CD18 в крови пациентов с ожоговой травмой. Актуальные проблемы медицины и биологии. 2004;3(2):294–295.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Fang Y, Chen Y, Ge S. The effect of PMN adhesion mediated by CD11b/CD18 on the increasing permeability of microvascular endothelial monolayer after severe burn injury. Zhonghua Yi Xue Za Zhi. 1998;78(10):746–748.</mixed-citation><mixed-citation xml:lang="en">Fang Y, Chen Y, Ge S. The effect of PMN adhesion mediated by CD11b/CD18 on the increasing permeability of microvascular endothelial monolayer after severe burn injury. Zhonghua Yi Xue Za Zhi. 1998;78(10):746–748.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatia R, Dent C, Topley N, Pallister I. Neutrophil priming for elastase release in adult blunt trauma patients. J Trauma. 2006;60(3):590–596.</mixed-citation><mixed-citation xml:lang="en">Bhatia R, Dent C, Topley N, Pallister I. Neutrophil priming for elastase release in adult blunt trauma patients. J Trauma. 2006;60(3):590–596.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Бабаев А.А., Ежова Г.П., Новиков В.В., Лебедев М.Ю. Мембранная и растворимая формы белка CD50 при ожогах. Вестник ННГУ. Серия – биология. 2005;1(6):252–256.</mixed-citation><mixed-citation xml:lang="en">Бабаев А.А., Ежова Г.П., Новиков В.В., Лебедев М.Ю. Мембранная и растворимая формы белка CD50 при ожогах. Вестник ННГУ. Серия – биология. 2005;1(6):252–256.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Бабаев А.А., Лебедев М.Ю., Новиков В.В. Сывороточный уровень растворимого CD50 антигена и относительное содержание CD50 положительных мононуклеарных клеток при ожогах. Медицинская иммунология. 2006;8(5-6):727–731.</mixed-citation><mixed-citation xml:lang="en">Бабаев А.А., Лебедев М.Ю., Новиков В.В. Сывороточный уровень растворимого CD50 антигена и относительное содержание CD50 положительных мононуклеарных клеток при ожогах. Медицинская иммунология. 2006;8(5-6):727–731.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Bernasconi S., Matteucci C., Sironi M. et al. Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages Int. J. Cancer. 1995;60(3):300–307.</mixed-citation><mixed-citation xml:lang="en">Bernasconi S., Matteucci C., Sironi M. et al. Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages Int. J. Cancer. 1995;60(3):300–307.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Lebedev M. Ju., Krizhanova M.A., Vilkov S.A. et al. Peripheral blood lymphocytes immunophenotype and serum concentration of soluble HLA class I in burn patients. Burns. 2003;29(2):123–128.</mixed-citation><mixed-citation xml:lang="en">Lebedev M. Ju., Krizhanova M.A., Vilkov S.A. et al. Peripheral blood lymphocytes immunophenotype and serum concentration of soluble HLA class I in burn patients. Burns. 2003;29(2):123–128.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков В.В., Караулов А.В., Барышников А.Ю. Растворимые формы мембранных антигенов клеток иммунной системы. Иммунология, 2007;4:249–253.</mixed-citation><mixed-citation xml:lang="en">Новиков В.В., Караулов А.В., Барышников А.Ю. Растворимые формы мембранных антигенов клеток иммунной системы. Иммунология, 2007;4:249–253.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков В.В., Караулов А.В., Барышников А.Ю. и др. Особенности структурного состояния пула растворимых форм мембранных антигенов клеток иммунной системы. Молекулярная медицина. 2009;4:34–38.</mixed-citation><mixed-citation xml:lang="en">Новиков В.В., Караулов А.В., Барышников А.Ю. и др. Особенности структурного состояния пула растворимых форм мембранных антигенов клеток иммунной системы. Молекулярная медицина. 2009;4:34–38.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Лебедев М.Ю., Сизова Е.Н., Новиков В.В. Содержание растворимых форм CD8 антигена, молекул HLA-I класса и их ассоциатов в сыворотке крови у обожженных пациентов. Российский иммунологический журнал. 2008;2 (11):133–134.</mixed-citation><mixed-citation xml:lang="en">Лебедев М.Ю., Сизова Е.Н., Новиков В.В. Содержание растворимых форм CD8 антигена, молекул HLA-I класса и их ассоциатов в сыворотке крови у обожженных пациентов. Российский иммунологический журнал. 2008;2 (11):133–134.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
